XHE:NYE-SPDR® S&P Health Care Equipment ETF (USD)

ETF | Health |

Last Closing

USD 86.15

Change

-1.46 (-1.67)%

Market Cap

USD 0.22B

Volume

7.08K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

In seeking to track the performance of the S&P Health Care Equipment Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the health care equipment segment of the S&P Total Market Index (S&P TMI).

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-07 )

Largest Industry Peers for Health

Symbol Name Price(Change) Market Cap
XLV Health Care Select Sector SPDR..

-0.67 (-0.44%)

USD 41.04B
FHLC Fidelity® MSCI Health Care In..

-0.48 (-0.67%)

USD 2.94B
FXH First Trust Health Care AlphaD..

-1.47 (-1.35%)

USD 1.23B
IDNA iShares Genomics Immunology an..

-0.33 (-1.34%)

USD 0.14B
SBIO ALPS Medical Breakthroughs ETF

-0.86 (-2.28%)

USD 0.11B
XHS SPDR® S&P Health Care Service..

-1.15 (-1.22%)

USD 0.08B
HTEC Robo Global® Healthcare Techn..

-0.29 (-1.00%)

USD 0.06B
BBP Virtus LifeSci Biotech Product..

-1.14 (-1.82%)

USD 0.02B
BBC Virtus LifeSci Biotech Clinica..

N/A

USD 0.01B
IHE iShares U.S. Pharmaceuticals E..

-0.31 (-0.43%)

N/A

ETFs Containing XHE

INAV 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -48.88% 29% F 10% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -48.88% 29% F 10% F
Trailing 12 Months  
Capital Gain -42.75% 38% F 10% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -42.75% 38% F 10% F
Trailing 5 Years  
Capital Gain -42.42% 29% F 16% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -42.42% 29% F 16% F
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 0.22B 70% C- 36% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.